Amgen Rebuilt R&D Platform To Focus On Speed And Access

Genetics, AI And Other Tools Assembled Over Past Decade

 
• By Mandy Jackson
  
Samples of DNA in a multi well plate ready for analysis with DNA results in the background
Amgen's first big investment in genomics was the acquisition of decode in 2012 • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business